Clinical trials: Sarbecovirus
Healthy Participants, Sarbecovirus
A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.
The purpose of this research study is to evaluate the safety of and the body's immune response to single and multiple vaccinations in healthy men and women. We want to find out what effects GBP511 has on you and your health.
- Trial name
- NCT07280858
- Testing
- Test Drug 1-1 (GBP511 low dose), Test Drug 1-2 (GBP511 mid dose), Test Drug 1-3 (GBP511 high dose)
- Where
- 3 sites in Australia
- Volunteers
- 368 people, healthy volunteers welcome
- Sponsor
- SK Bioscience Co., Ltd.